Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |